扎那米韦
神经氨酸酶
奥司他韦
突变体
病毒学
病毒
神经氨酸酶抑制剂
生物
甲型流感病毒
反向遗传学
野生型
病毒复制
抗性突变
正粘病毒科
分子生物学
基因
逆转录酶
遗传学
聚合酶链反应
医学
疾病
传染病(医学专业)
病理
2019年冠状病毒病(COVID-19)
作者
Yacine Abed,Nathalie Goyette,Guy Boivin
标识
DOI:10.1177/135965350400900404
摘要
A system of reverse genetics was used to generate influenza A/H1N1 viruses harbouring neuraminidase (NA) mutations previously associated with resistance to NA inhibitors in various viral subtypes. The His274Tyr and Glu119Gln mutants were rescued whereas the Arg292Lys and Glu1l9 --> Gly, Val, Ala or Asp mutants could not be generated. In NA inhibition assays, the His274Tyr mutant was resistant to oseltamivir (430-fold over wild-type) and BCX-1812 (50-fold) but was sensitive to zanamivir. A similar trend was seen when the mutant was evaluated by plaque reduction assay (PRA). The Glu119Gln mutant expressed a low level of resistance to oseltamivir (nine-fold) and zanamivir (fourfold) in NA inhibition assay but was only marginally resistant to oseltamivir (fourfold) in PRA. The replication capacity of both mutants, in particular that of the His274Tyr virus, was impaired when compared with the wild-type virus in vitro.
科研通智能强力驱动
Strongly Powered by AbleSci AI